Transcriptional Repressor Activating Transcription Factor 3 Protects Human Umbilical Vein Endothelial Cells from Tumor Necrosis Factor-α-induced Apoptosis through Down-regulation ofp53 Transcription

This publication has 40 references indexed in Scilit:

• ATF3 Represses 72-kDa Type IV Collagenase (MMP-2) Expression by Antagonizing p53-dependent trans-Activation of the Collagenase Promoter
  Published by Elsevier ,2002
• Transgenic Mice with Cardiac-Specific Expression of Activating Transcription Factor 3, a Stress-Inducible Gene, Have Conduction Abnormalities and Contractile Dysfunction
  The American Journal of Pathology, 2001
• Increased Expression and Activation of Stress-Activated Protein Kinases/c-Jun NH2-Terminal Protein Kinases in Atherosclerotic Lesions Coincide with p53
  The American Journal of Pathology, 2000
• Differential regulation of mitogen-activated protein kinases by microtubule-binding agents in human breast cancer cells
  Oncogene, 1999
• DNA damage activates p53 through a phosphorylation–acetylation cascade
  Genes & Development, 1998
• Resistance of MCF7 human breast carcinoma cells to TNF-induced cell death is associated with loss of p53 function
  Oncogene, 1997
• Regulation of p53 stability by Mdm2
  Nature, 1997
• Mdm2 promotes the rapid degradation of p53
  Nature, 1997
• Apoptosis by Death Factor
  Cell, 1997
• Dissection of TNF Receptor 1 Effector Functions: JNK Activation Is Not Linked to Apoptosis While NF-κB Activation Prevents Cell Death
  Cell, 1996